×

IMMUNE EFFECTOR CELL THERAPIES WITH ENHANCED EFFICACY

  • US 20190000880A1
  • Filed: 12/30/2016
  • Published: 01/03/2019
  • Est. Priority Date: 12/30/2015
  • Status: Active Application
First Claim
Patent Images

1. A method of treating a subject, comprising administering to said subject an LSD1 inhibitor and a population of immune effector cells engineered to express a CAR.

View all claims
  • 7 Assignments
Timeline View
Assignment View
    ×
    ×